• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reply to letter regarding "Percutaneous needle fasciotomy for Dupuytren's disease: A one-stop approach incidentally suited to the era of COVID-19".

作者信息

Patel Manal I A, Patel Irshad A

机构信息

University of Cambridge School of Clinical Medicine, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0SP, UK.

Department of Plastic and Reconstructive Surgery, Royal Devon & Exeter Hospital, Barrack Road, Exeter, EX2 5DW, UK.

出版信息

J Plast Reconstr Aesthet Surg. 2021 Jul;74(7):1633-1701. doi: 10.1016/j.bjps.2021.01.018. Epub 2021 Feb 10.

DOI:10.1016/j.bjps.2021.01.018
PMID:33602573
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7874971/
Abstract
摘要

相似文献

1
Reply to letter regarding "Percutaneous needle fasciotomy for Dupuytren's disease: A one-stop approach incidentally suited to the era of COVID-19".关于“经皮针状筋膜切开术治疗掌腱膜挛缩症：一种适用于COVID-19时代的一站式方法”的信件回复
J Plast Reconstr Aesthet Surg. 2021 Jul;74(7):1633-1701. doi: 10.1016/j.bjps.2021.01.018. Epub 2021 Feb 10.
2
Percutaneous needle fasciotomy for Dupuytren's disease: A one-stop approach incidentally suited to the era of COVID-19.经皮针状筋膜切开术治疗掌腱膜挛缩症：一种适用于 COVID-19 时代的一站式方法。
J Plast Reconstr Aesthet Surg. 2020 Nov;73(11):2086-2102. doi: 10.1016/j.bjps.2020.08.037. Epub 2020 Aug 29.
3
[The Extended Percutaneous Needle Fasciotomy Technique (PNF+) For Dupuytren's Contracture].[用于掌腱膜挛缩症的改良经皮针状筋膜切开术技术（PNF+）]
Handchir Mikrochir Plast Chir. 2017 Feb;49(1):47-50. doi: 10.1055/s-0043-102687. Epub 2017 Apr 19.
4
Percutaneous needle fasciotomy for Dupuytren's disease: Minimizing morbidity.
J Plast Reconstr Aesthet Surg. 2017 Jul;70(7):984-985. doi: 10.1016/j.bjps.2017.02.010. Epub 2017 Feb 27.
5
Needle aponeurotomy: a treatment alternative for Dupuytren's disease.针式腱膜切开术：治疗掌腱膜挛缩症的一种替代疗法。
S D Med. 2011 Nov;64(11):411, 413, 415 passim.
6
A feasibility study investigating the acceptability and design of a multicentre randomised controlled trial of needle fasciotomy versus limited fasciectomy for the treatment of Dupuytren's contractures of the fingers (HAND-1): study protocol for a randomised controlled trial.一项关于针状筋膜切开术与有限筋膜切除术治疗手指掌腱膜挛缩症的多中心随机对照试验的可接受性和设计的可行性研究（HAND-1）：一项随机对照试验的研究方案
Trials. 2017 Aug 25;18(1):392. doi: 10.1186/s13063-017-2127-9.
7
Ultrasound-Assisted Percutaneous Needle Fasciotomy for Dupuytren's Contracture.超声辅助经皮针状筋膜切开术治疗掌腱膜挛缩症
Orthopedics. 2015 May;38(5):299-303. doi: 10.3928/01477447-20150504-03.
8
Analysis of recurrence and complications after percutaneous needle fasciotomy in Dupuytren's disease.掌腱膜挛缩症经皮针刀松解术后复发及并发症分析。
Arch Orthop Trauma Surg. 2019 Oct;139(10):1471-1477. doi: 10.1007/s00402-019-03247-y. Epub 2019 Jul 31.
9
Repeated percutaneous needle fasciotomy for recurrent Dupuytren's disease.复发性Dupuytren病的重复经皮针筋膜切开术
J Hand Surg Eur Vol. 2024 Jan;49(1):109-111. doi: 10.1177/17531934231194691. Epub 2023 Oct 24.
10
Dupuytren's contracture: an analysis of outcomes of percutaneous needle fasciotomy versus open fasciectomy.杜普伊特伦挛缩症：经皮针状筋膜切开术与开放性筋膜切除术的疗效分析
ANZ J Surg. 2015 Sep;85(9):639-43. doi: 10.1111/ans.12513. Epub 2014 Jan 20.

本文引用的文献

1
Dupuytren's disease treatment during the second wave of COVID-19 pandemic.新冠疫情第二波期间的掌腱膜挛缩症治疗
J Plast Reconstr Aesthet Surg. 2021 Mar;74(3):644-710. doi: 10.1016/j.bjps.2020.12.030. Epub 2020 Dec 24.
2
Versatility of percutaneous needle fasciotomy for Dupuytren's disease across a spectrum of disease severity: A single-surgeon experience of 118 rays.经皮针状筋膜切开术治疗不同严重程度杜普伊特伦挛缩症的多功能性：一位外科医生对118根手指的治疗经验
JPRAS Open. 2020 Nov 30;27:80-89. doi: 10.1016/j.jpra.2020.11.008. eCollection 2021 Mar.
3
Collagenase Treatment of Dupuytren's Disease with Minimum 5-Year Follow-Up: Recurrence, Reintervention, and Satisfaction.胶原酶治疗掌腱膜挛缩症：至少 5 年随访结果——复发、再次干预和满意度。
Plast Reconstr Surg. 2020 Nov;146(5):1071-1079. doi: 10.1097/PRS.0000000000007243.
4
Cost-effectiveness of Recurrent Dupuytren Contracture Treatment.复发性掌腱膜挛缩治疗的成本效益。
JAMA Netw Open. 2020 Oct 1;3(10):e2019861. doi: 10.1001/jamanetworkopen.2020.19861.
5
Percutaneous needle fasciotomy for Dupuytren's disease: A one-stop approach incidentally suited to the era of COVID-19.经皮针状筋膜切开术治疗掌腱膜挛缩症：一种适用于 COVID-19 时代的一站式方法。
J Plast Reconstr Aesthet Surg. 2020 Nov;73(11):2086-2102. doi: 10.1016/j.bjps.2020.08.037. Epub 2020 Aug 29.